MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · IEX Real-Time Price · USD
15.41
-0.20 (-1.28%)
Apr 22, 2024, 4:00 PM EDT - Market closed
MacroGenics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for MacroGenics stock have an average target of 21.5, with a low estimate of 12 and a high estimate of 29. The average target predicts an increase of 39.52% from the current stock price of 15.41.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 11, 2024.
Analyst Ratings
The average analyst rating for MacroGenics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 4 | 5 | 6 |
| Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 7 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Apr 9, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 4, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $25 | Strong Buy | Maintains | $13 → $25 | +62.23% | Mar 11, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $16 → $22 | Buy | Maintains | $16 → $22 | +42.76% | Mar 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | +3.83% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
68.12M
from 58.75M
Increased by 15.96%
Revenue Next Year
136.37M
from 68.12M
Increased by 100.18%
EPS This Year
-2.60
from -0.15
EPS Next Year
-1.04
from -2.60
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 132.0M | 342.5M | 160.3M | 155.8M | 227.9M |
| Avg | 68.1M | 136.4M | 71.4M | 100.9M | 133.8M |
| Low | 35.2M | 32.6M | 21.6M | 48.5M | 44.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 124.7% | 402.8% | 17.6% | 118.0% | 125.8% |
| Avg | 16.0% | 100.2% | -47.6% | 41.2% | 32.6% |
| Low | -40.1% | -52.1% | -84.2% | -32.1% | -56.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.85 | 3.52 | -2.04 | -1.85 | -1.31 |
| Avg | -2.60 | -1.04 | -2.60 | -1.80 | -1.28 |
| Low | -3.13 | -2.70 | -3.68 | -1.72 | -1.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.